We regret to inform you that we will no longer be publishing Health Data Management. It has been an honor to provide you with the insights and connections to move your career forward. We wish you continued success on your professional journey and welcome you to explore our other titles at www.arizent.com/brands.

PatientSafe, ILUM Health join to offer infectious disease alerts

Two mobile communications platform vendors have teamed up to expedite delivery of infectious disease alerts and other critical patient information to nurses and other clinicians via their smartphones.

PatientSafe Solutions offers a platform that supports secure messaging, voice calls, critical alerts, nurse calls, nursing documentation and a mobile application to improve clinical workflows. ILUM Health Solutions, a subsidiary of Merck Healthcare Services, has a platform to target at-risk patients to support interventions, track clinician performance, prescribing and outcomes, and enhance clinical communications within a workflow.

Also See: 5 ways smartphones can be linked to hospital systems

PatientSafe’s strength in delivering real-time clinical information to a care team’s phones will match with ILUM’s ability to rapidly extract and synthesize critical data from the pharmacy and lab, says Si Luo, president and CEO at PatientSafe.

“Our integration will enable hospitals to help improve adherence to established clinical pathways for antimicrobial stewardship and sepsis, leading to better infectious disease outcomes,” he adds.

ILUM’s technology analyses patient data in accordance with a hospital’s specific guidelines and identifies high-risk patients and intervention opportunities. Notifications from ILUM are routed in real-time to the assigned caregiver or a team of clinicians. This enables immediate triage and rapid coordination between the care team and the pharmacy.

A pilot program started in late February, and the vendors expect the joint solution to go live with clients in this summer. Improved efficiency, productivity and outcomes are the expected return on investment, according to Luo.

For reprint and licensing requests for this article, click here.